Absci Corporation (ABSI) Financials

ABSI Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 268.9 million 22.8 million
March 31, 2026 195.6 million 23.6 million
Dec. 31, 2025 216.3 million 26.8 million
Sept. 30, 2025 245.0 million 34.7 million

ABSI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -27.6 million 5.2 million
March 31, 2026 -26.3 million 4.4 million
Dec. 31, 2025 -29.1 million 4.3 million
Sept. 30, 2025 -26.0 million 4.4 million

ABSI Net Income

No data available :(

ABSI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 201.1 million - 3.7 million
March 31, 2026 125.7 million - 2.1 million
Dec. 31, 2025 144.3 million - 2.6 million
Sept. 30, 2025 152.5 million 65000 4.8 million

ABSI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 157.5 million
March 31, 2026 153.0 million
Dec. 31, 2025 150.6 million
Sept. 30, 2025 143.8 million

ABSI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1000 22.6 million 9.2 million -
March 31, 2026 30000 19.3 million 9.1 million -
Dec. 31, 2025 103000 25.3 million 8.6 million -
Sept. 30, 2025 962000 19.2 million 8.4 million -

ABSI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 318000 -
March 31, 2026 215000 2.7 million
Dec. 31, 2025 650000 2.8 million
Sept. 30, 2025 378000 -

ABSI

Price: $9.49

52 week price:
2.24
12.06

Earnings Per Share: -0.79 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 382100

Market Capitalization: 1.5 billion

Links: